G9820 – Documentation of a chlamydia screening test with proper follow-up

Long description

Documentation of a chlamydia screening test with proper follow-up

Short description

Doc chlam scr test w/follow

Pricing indicator

00 Not separately priced by Part B (bundled, not covered or Part A only)

Medicare coverage

C Carrier judgment – coverage decided by the Medicare contractor

BETOS category

Z2 Undefined codes

Added

January 1, 2017

Last change

January 1, 2017 – No change

Nearby G codes

• G9812 – Patient died including all deaths occurring during the hospitalization in which the operation was performed, even if after 30 days, and those deaths occurring after discharge from the hospital, but within 30 days of the procedure
• G9813 – Patient did not die within 30 days of the procedure or during the index hospitalization
• G9814 – Death occurring during the index acute care hospitalization
• G9815 – Death did not occur during the index acute care hospitalization
• G9816 – Death occurring after discharge from the hospital but within 30 days post procedure
• G9817 – Death did not occur after discharge from the hospital within 30 days post procedure
• G9818 – Documentation of sexual activity
• G9819 – Patients who use hospice services any time during the measurement period
• G9821 – No documentation of a chlamydia screening test with proper follow-up
• G9822 – Patients who had an endometrial ablation procedure during the 12 months prior to the index date (exclusive of the index date)
• G9823 – Endometrial sampling or hysteroscopy with biopsy and results documented during the 12 months prior to the index date (exclusive of the index date) of the endometrial ablation
• G9824 – Endometrial sampling or hysteroscopy with biopsy and results not documented during the 12 months prior to the index date (exclusive of the index date) of the endometrial ablation
• G9825 – Her-2/neu negative or undocumented/unknown
• G9826 – Patient transferred to practice after initiation of chemotherapy
• G9827 – Her2-targeted therapies not administered during the initial course of treatment
• G9828 – Her2-targeted therapies administered during the initial course of treatment